These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11463812)

  • 1. The insert region of RhoA is essential for Rho kinase activation and cellular transformation.
    Zong H; Kaibuchi K; Quilliam LA
    Mol Cell Biol; 2001 Aug; 21(16):5287-98. PubMed ID: 11463812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
    Guo F; Zheng Y
    Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation.
    Sahai E; Alberts AS; Treisman R
    EMBO J; 1998 Mar; 17(5):1350-61. PubMed ID: 9482732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of cyclooxygenase 2 expression by small GTPases Ras, Rac1, and RhoA.
    Chang YW; Putzer K; Ren L; Kaboord B; Chance TW; Qoronfleh MW; Jakobi R
    J Cell Biochem; 2005 Oct; 96(2):314-29. PubMed ID: 16088958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
    Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
    Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways.
    Martin CB; Mahon GM; Klinger MB; Kay RJ; Symons M; Der CJ; Whitehead IP
    Oncogene; 2001 Apr; 20(16):1953-63. PubMed ID: 11360179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
    Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
    Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
    Zohn IM; Campbell SL; Khosravi-Far R; Rossman KL; Der CJ
    Oncogene; 1998 Sep; 17(11 Reviews):1415-38. PubMed ID: 9779988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of p21Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton.
    Coleman ML; Densham RM; Croft DR; Olson MF
    Oncogene; 2006 May; 25(19):2708-16. PubMed ID: 16407839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CrkII induces serum response factor activation and cellular transformation through its function in Rho activation.
    Iwahara T; Akagi T; Shishido T; Hanafusa H
    Oncogene; 2003 Sep; 22(38):5946-57. PubMed ID: 12955073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFbeta3-induced activation of RhoA/Rho-kinase pathway is necessary but not sufficient for epithelio-mesenchymal transdifferentiation: implications for palatogenesis.
    Kaartinen V; Haataja L; Nagy A; Heisterkamp N; Groffen J
    Int J Mol Med; 2002 Jun; 9(6):563-70. PubMed ID: 12011971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of Rho in cell transformation by oncogenic Ras.
    Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ
    Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular decipherment of Rho effector pathways regulating tight-junction permeability.
    Fujita H; Katoh H; Hasegawa H; Yasui H; Aoki J; Yamaguchi Y; Negishi M
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):617-22. PubMed ID: 10698687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoE inhibits cell cycle progression and Ras-induced transformation.
    Villalonga P; Guasch RM; Riento K; Ridley AJ
    Mol Cell Biol; 2004 Sep; 24(18):7829-40. PubMed ID: 15340047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine phosphorylation differentially affects RhoA binding to effectors: implications to NGF-induced neurite outgrowth.
    Nusser N; Gosmanova E; Makarova N; Fujiwara Y; Yang L; Guo F; Luo Y; Zheng Y; Tigyi G
    Cell Signal; 2006 May; 18(5):704-14. PubMed ID: 16109481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.